Quarterly report pursuant to Section 13 or 15(d)

NATURE OF OPERATIONS (Details)

v3.24.1.1.u2
NATURE OF OPERATIONS (Details) - USD ($)
 1 Months Ended 3 Months Ended
Nov. 15, 2023
May 16, 2023
Jul. 25, 2022
Jun. 29, 2021
Feb. 28, 2018
Mar. 31, 2024
Dec. 31, 2023
Warrant exercise price (in dollars per share)   $ 2.9999 $ 3.60        
Shares issued (in shares)   601,851 1,159,211 2,875,000      
Gross proceeds from stock issue   $ 4,000,000.0 $ 4,200,000 $ 17,300,000      
Share price (in dollars per share)   $ 3.00   $ 6.00      
Pre-funded Warrant Exercise (in shares)   731,482 130,769        
Cash           $ 8,920,926 $ 7,474,188
Number of warrants   731,482 63,018        
Series A warrants              
Number of warrants     1,289,980        
Series B warrants              
Number of warrants     1,289,980        
Series C warrants              
Warrant exercise price (in dollars per share)   $ 3.26          
Number of warrants   1,333,333          
Series D warrants              
Warrant exercise price (in dollars per share)   $ 3.26          
Number of warrants   1,333,333          
At the Market Offering              
Shares issued (in shares)           1,121,793  
Gross proceeds from stock issue           $ 4,400,000  
Aggregate offering price $ 17,000,000.0         $ 9,900,000  
At the Market Offering | Aggregate              
Shares issued (in shares)           1,819,914  
Gross proceeds from stock issue           $ 7,100,000  
ACX362E              
Cash paid         $ 110,174    
Future commitment         700,000    
Royalty payments         $ 50,000    
Royalty payments on net sales (as a percent)         4.00%    
ACX362E | Members' Equity, Class B              
Granting (in shares)         100,000    
Warrant exercise price (in dollars per share)         $ 0.10